Shasun Pharma receives FDA approval for pain relief drug Carisoprodol

Shasun Pharmaceuticals has received approval from US Food and Drug Administration (FDA) for Carisoprodol tablets, used as pain relief drug, in 250 mg and 350 mg strengths.
 
Carisoprodol tablets (250 mg and 350 mg) have sales of approximately $38 million. While the 350 mg has a few generic players, Shasun expects to be the first marketed generic player in the $16 million Carisoprodol tablets of 250 mg opportunity, said the company in a press release.
 
Shasun Pharmaceuticals will manufacture the product at its Puducherry plant and distributed in US through a partner.
 
Carisoprodol, which is a muscle relaxer that works by blocking pain sensations between the nerves and the brain, is used together with rest and physical therapy to treat injuries and other painful musculoskeletal conditions.